Back to discover
Disease

Disease Susceptibility

Actively researchedRising momentum
89
Publications
12
Related conditions
7
Related proteins
2025
Latest publication
Current focus
Amyloid beta biologyCarrier biologyDiagnosis & biomarkersGenetics & risk factorsInflammation & immunityMetabolic & lifestyle factors
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Tumor-Infiltrating Immune Cells in Colorectal Cancer.

Research2024-12-05Neoplasia (New York, N.Y.)

Aging and cancer.

Research2024-05-18Molecular cancer

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Therapeutic landscape

Therapies with a regulatory footing for this condition, alongside the wider set of agents co-studied with it in the literature.

Approved & established therapies
Oseltamivirapproved

Approval — Treatment of influenza Tamiflu is indicated in adults and children including full term ne… (2002)

Regulatory timeline

Drug regulatory events matched to this condition by indication — EMA.

First approvals
2002emaApprovalOseltamivir· Treatment of influenza Tamiflu is indicated in adults and children including full term neonates who present with symptoms typical of influenza, when influenza virus is circulating in the community. Efficacy has been demonstrated when treatment is initiated within two days of first onset of symptoms.Prevention of influenza Post-exposure prevention in individuals one year of age or older following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community. The appropriate use of Tamiflu for prevention of influenza should be determined on a case-by-case basis by the circumstances and the population requiring protection. In exceptional situations (e.g. in case of a mismatch between the circulating and vaccine virus strains, and a pandemic situation) seasonal prevention could be considered in individuals one year of age or older. Tamiflu is indicated for post-exposure prevention of influenza in infants less than 1 year of age during a pandemic-influenza outbreak. Tamiflu is not a substitute for influenza vaccination. The use of antivirals for the treatment and prevention of influenza should be determined on the basis of official recommendations. Decisions regarding the use of oseltamivir for treatment and prophylaxis should take into consideration what is known about the characteristics of the circulating influenza viruses, available information on influenza drug susceptibility patterns for each season and the impact of the disease in different geographical areas and patient populations. source ↗

European Medicines Agency (CC BY 4.0). Events are matched to this condition by drug indication text — approvals/updates for drugs indicated for it, not disease-specific acts.

Research activity

89 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20142025
Major themes8
  • Disease Susceptibility17
  • Gastrointestinal Microbiome9
  • Immunity5
  • Tumor Microenvironment4
  • Biomarkers, Tumor3
  • Autophagy2
  • Betacoronavirus2
  • Biomarkers2
Leading journals6
  • Frontiers in immunology20
  • International journal of molecular sciences11
  • Molecular cancer10
  • EBioMedicine5
  • Frontiers in cellular and infection microbiology3
  • Journal of immunology research3
Leading researchers8
  • Wang S3
  • Akdis CA2
  • Brüggen MC2
  • Jiang P2
  • Kanneganti TD2
  • Kesavardhana S2
  • Kroemer G2
  • Li M2
Affiliations (unnormalised)6
  • School of Medicine5
  • St. Jude Children's Research Hospital3
  • University of California3
  • Abramson Cancer Center2
  • Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.2
  • Centre de Recherche des Cordeliers2

Disease biology

7 matches

Key proteins & gene products studied in this disease. Number shows shared papers.

Related conditions

12 matches

Diseases frequently studied alongside this one. Number shows shared papers.

Disease profile

A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.

Overview

Disease susceptibility refers to a constitutional or bodily condition that makes tissues react in special ways to certain external stimuli, increasing the likelihood of developing particular diseases. The supplied literature grounding treats it as a broad host-state concept rather than a single disease entity. Its coverage is mainly immunologic and epidemiologic, with examples spanning inflammatory, infectious, neurodegenerative, and cancer-related contexts.

Causes

The grounding does not support a single cause or aetiology for disease susceptibility. It is described as a general predisposition shaped by the body's condition and by interactions with extrinsic stimuli. The supplied abstracts also point to multifactorial influences in specific diseases, including genetics, infections, environmental factors, and tissue microenvironmental signals, but not as causes of susceptibility itself.

Pathophysiology

The grounding supports a broad mechanism in which host responses to external stimuli are altered through immune, inflammatory, and signaling pathways. Co-studied mechanisms include signal transduction, immunity, innate immunity, immunomodulation, host-pathogen interactions, gastrointestinal microbiome effects, energy metabolism, and tumor microenvironment interactions. The literature also links susceptibility-related biology to cytokine activity, immune checkpoint proteins, membrane and carrier proteins, and inflammatory mediators.

Risk factors

The grounding does not provide disease-specific risk factors for susceptibility as a standalone entity. In the supplied abstracts, factors associated with increased disease risk in specific conditions include age, genetic factors, head injuries, vascular disease, infections, environmental factors, and altered immune or tumor microenvironment states. These are examples from related diseases rather than validated risk factors for the general concept of disease susceptibility.

AI-generated summary grounded in MeSH and 6 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.